Intervention Review

Short-acting beta2-agonists for stable chronic obstructive pulmonary disease

  1. Piersante Sestini1,*,
  2. E Renzoni2,
  3. Stewart Robinson3,
  4. Phillippa Poole4,
  5. Felix SF Ram5

Editorial Group: Cochrane Airways Group

Published Online: 22 JUL 2002

Assessed as up-to-date: 13 MAY 2002

DOI: 10.1002/14651858.CD001495

How to Cite

Sestini P, Renzoni E, Robinson S, Poole P, Ram FSF. Short-acting beta2-agonists for stable chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2002, Issue 3. Art. No.: CD001495. DOI: 10.1002/14651858.CD001495.

Author Information

  1. 1

    University of Siena, Institute of Respiratory Diseases, Siena, Italy

  2. 2

    Royal Brompton Hospital, London, UK

  3. 3

    School of Medicine, Department of Physiology, Auckland, New Zealand

  4. 4

    University of Auckland, Auckland, New Zealand

  5. 5

    Massey University - Auckland, School of Health Sciences, Auckland, New Zealand

*Piersante Sestini, Institute of Respiratory Diseases, University of Siena, Viale Bracci 3, 53100, Siena, Italy.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 22 JUL 2002


Options for accessing this content:

  • If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
  • Login via other institutional login options
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens


Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.